ʻaoʻao_banner

Nā huahana

N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly Cas:64967-39-1 99% Keʻokeʻo a keʻokeʻo pauda

ʻO ka wehewehe pōkole:

Ka helu helu: XD90187
Cas: 64967-39-1
ʻAno Molekala: C20H21N3O6
Kaumaha Molekala: 399.39
Loaʻa: Loaʻa
Kumukuai:  
Hoʻopili mua: 1g USD30
Pūʻulu Nui: Noi Manao

 

 

 

 

 

 

 


Huahana Huahana

Huahana Huahana

Helu Helu XD90187
inoa mea kūʻai N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly
CAS 64967-39-1
ʻĀpana Molekala C20H21N3O6
Kaumaha Molecular 399.39
Nā kikoʻī mālama -15 a -20 °C
Kānāwai Kūʻai Kūlike 29321900

 

Huahana Huahana

Ka nana aku ʻO ka pauka keʻokeʻo keʻokeʻo
ʻO Assay ≥99%
Lae hehee 245 °C (Dek.)(kumu)
Ka hikiwawe NH4OH 1 M: 50 mg/mL, ʻaʻaʻa a hiki i ka pohu iki, melemele

PSA 137.74000

 

Ma ke ʻano kinetic angiotensin-converting enzyme (ACE), he 80 mmol/L borate buffer ma ka pH 8.2 (37 degere C).ʻIke ʻia kahi pae lag i ka hopena, a manaʻo ʻia kahi incubation 5-min o ka substrate a me ka plasma ma mua o ke ana kinetic.ʻO ka substrate, N-[3-(2-furyl)acryloyl]-L-phenylalanylglycylglycine (FAPGG), ua hoʻonui ʻia ka manaʻo ma 1.0 mmol/L a ʻo ka lōʻihi o ke ana ma 345 nm e hōʻoia i ka linearity o ke ana.Hoʻohana ʻia ke kaʻina hana i ka 1:9 plasma-to-reagent volume ratio.Hoʻonui ka laina laina o ka assay ma kahi o 170 U/L, e hōʻike ana i kahi 25% substrate hydrolysis.Hoʻoholo ʻia ka absorptivity FAPGG ma ke ana ʻana i ka ʻokoʻa o ka absorbance ma waena o 1.0 mmol/L FAPGG a me nā hoʻonā huahana.Hoʻopaʻa ʻia ka ʻoiaʻiʻo o ka nalu ma ka ʻike ʻana i ka waiwai absorbance i manaʻo ʻia o ka solution FAPGG, a he 1.0-nm deviation mai 345 nm e hoʻololi i ka absorbance e 15.5%.ʻO ka pololei o ka ACE assays ma kahi o 60 a me 100 U/L ʻo 3.5% a me 2.4% i loko o ka pūʻulu a me 2.9% a me 2.6% ma waena o ka pūʻulu.He 41-139 U/L ka manawa kuhikuhi (2.5th a 97.5th percentiles), a ʻaʻohe ʻokoʻa ma waena o nā waiwai no nā kāne a me nā wahine.


  • Mua:
  • Aʻe:

  • Pani

    N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly Cas:64967-39-1 99% Keʻokeʻo a keʻokeʻo pauda